<p>NEW YORK (Reuters) Michael Tardugno, arch executive of little Celsion Corp, is assured he has a $1 billion cancer therapy on his hands with a ThermoDox diagnosis for liver cancer.
The company, with a marketplace gratefulness of usually about $70 million and all of 16 employees, is not perplexing to reinvent a wheel. But by fixation a really aged cancer drug a chemotherapy doxorubicin into a new smoothness routine and adding heat, Celsion believes it has a recipe for success that can residence a vast need in cancer.
Certainly this is a $1 billion drug, Tardugno told Reuters in an interview.
We dont move a newest biotechnology to marketplace in a drug system, he said. We have a ability to take a really earnest record and request it to an unmet medical need.
About 750,000 new cases of liver cancer are diagnosed any year. The World Health Organization has likely that by 2020 liver cancer will transcend lung as a No. 1 canc...
Wednesday, 20 June 2012
0 comments
Post a Comment